Ectopic bone formation by mesenchymal stem cells derived from human term placenta and the decidua

Gina D. Kusuma, Danijela Menicanin, Stan Gronthos, Ursula Manuelpillai, Mohamed H. Abumaree, Mark D. Pertile, Shaun P. Brennecke, Bill Kalionis

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) are one of the most attractive cell types for cell-based bone tissue repair applications. Fetal-derived MSCs and maternal-derived MSCs have been isolated from chorionic villi of human term placenta and the decidua basalis attached to the placenta following delivery, respectively. Chorionic-derived MSCs (CMSCs) and decidua-derived MSCs (DMSCs) generated in this study met the MSCs criteria set by International Society of Cellular Therapy. These criteria include: (i) adherence to plastic; (ii) >90% expression of CD73, CD105, CD90, CD146, CD44 and CD166 combined with <5% expression of CD45, CD19 and HLA-DR; and (iii) ability to differentiate into osteogenic, adipogenic, and chondrogenic lineages. In vivo subcutaneous implantation into SCID mice showed that both bromo-deoxyuridine (BrdU)-labelled CMSCs and DMSCs when implanted together with hydroxyapatite/tricalcium phosphate particles were capable of forming ectopic bone at 8-weeks post-transplantation. Histological assessment showed expression of bone markers, osteopontin (OPN), osteocalcin (OCN), biglycan (BGN), bone sialoprotein (BSP), and also a marker of vasculature, alpha-smooth muscle actin (α-SMA). This study provides evidence to support CMSCs and DMSCs as cellular candidates with potent bone forming capacity.

LanguageEnglish
Article numbere0141246
JournalPloS one
Volume10
Issue number10
DOIs
Publication statusPublished - 20 Oct 2015

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Kusuma, G. D., Menicanin, D., Gronthos, S., Manuelpillai, U., Abumaree, M. H., Pertile, M. D., ... Kalionis, B. (2015). Ectopic bone formation by mesenchymal stem cells derived from human term placenta and the decidua. PloS one, 10(10), [e0141246]. https://doi.org/10.1371/journal.pone.0141246
Kusuma, Gina D. ; Menicanin, Danijela ; Gronthos, Stan ; Manuelpillai, Ursula ; Abumaree, Mohamed H. ; Pertile, Mark D. ; Brennecke, Shaun P. ; Kalionis, Bill. / Ectopic bone formation by mesenchymal stem cells derived from human term placenta and the decidua. In: PloS one. 2015 ; Vol. 10, No. 10.
@article{167398b1bf4846e5b203c5cf21a0d3ea,
title = "Ectopic bone formation by mesenchymal stem cells derived from human term placenta and the decidua",
abstract = "Mesenchymal stem cells (MSCs) are one of the most attractive cell types for cell-based bone tissue repair applications. Fetal-derived MSCs and maternal-derived MSCs have been isolated from chorionic villi of human term placenta and the decidua basalis attached to the placenta following delivery, respectively. Chorionic-derived MSCs (CMSCs) and decidua-derived MSCs (DMSCs) generated in this study met the MSCs criteria set by International Society of Cellular Therapy. These criteria include: (i) adherence to plastic; (ii) >90{\%} expression of CD73, CD105, CD90, CD146, CD44 and CD166 combined with <5{\%} expression of CD45, CD19 and HLA-DR; and (iii) ability to differentiate into osteogenic, adipogenic, and chondrogenic lineages. In vivo subcutaneous implantation into SCID mice showed that both bromo-deoxyuridine (BrdU)-labelled CMSCs and DMSCs when implanted together with hydroxyapatite/tricalcium phosphate particles were capable of forming ectopic bone at 8-weeks post-transplantation. Histological assessment showed expression of bone markers, osteopontin (OPN), osteocalcin (OCN), biglycan (BGN), bone sialoprotein (BSP), and also a marker of vasculature, alpha-smooth muscle actin (α-SMA). This study provides evidence to support CMSCs and DMSCs as cellular candidates with potent bone forming capacity.",
author = "Kusuma, {Gina D.} and Danijela Menicanin and Stan Gronthos and Ursula Manuelpillai and Abumaree, {Mohamed H.} and Pertile, {Mark D.} and Brennecke, {Shaun P.} and Bill Kalionis",
year = "2015",
month = "10",
day = "20",
doi = "10.1371/journal.pone.0141246",
language = "English",
volume = "10",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

Kusuma, GD, Menicanin, D, Gronthos, S, Manuelpillai, U, Abumaree, MH, Pertile, MD, Brennecke, SP & Kalionis, B 2015, 'Ectopic bone formation by mesenchymal stem cells derived from human term placenta and the decidua', PloS one, vol. 10, no. 10, e0141246. https://doi.org/10.1371/journal.pone.0141246

Ectopic bone formation by mesenchymal stem cells derived from human term placenta and the decidua. / Kusuma, Gina D.; Menicanin, Danijela; Gronthos, Stan; Manuelpillai, Ursula; Abumaree, Mohamed H.; Pertile, Mark D.; Brennecke, Shaun P.; Kalionis, Bill.

In: PloS one, Vol. 10, No. 10, e0141246, 20.10.2015.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ectopic bone formation by mesenchymal stem cells derived from human term placenta and the decidua

AU - Kusuma, Gina D.

AU - Menicanin, Danijela

AU - Gronthos, Stan

AU - Manuelpillai, Ursula

AU - Abumaree, Mohamed H.

AU - Pertile, Mark D.

AU - Brennecke, Shaun P.

AU - Kalionis, Bill

PY - 2015/10/20

Y1 - 2015/10/20

N2 - Mesenchymal stem cells (MSCs) are one of the most attractive cell types for cell-based bone tissue repair applications. Fetal-derived MSCs and maternal-derived MSCs have been isolated from chorionic villi of human term placenta and the decidua basalis attached to the placenta following delivery, respectively. Chorionic-derived MSCs (CMSCs) and decidua-derived MSCs (DMSCs) generated in this study met the MSCs criteria set by International Society of Cellular Therapy. These criteria include: (i) adherence to plastic; (ii) >90% expression of CD73, CD105, CD90, CD146, CD44 and CD166 combined with <5% expression of CD45, CD19 and HLA-DR; and (iii) ability to differentiate into osteogenic, adipogenic, and chondrogenic lineages. In vivo subcutaneous implantation into SCID mice showed that both bromo-deoxyuridine (BrdU)-labelled CMSCs and DMSCs when implanted together with hydroxyapatite/tricalcium phosphate particles were capable of forming ectopic bone at 8-weeks post-transplantation. Histological assessment showed expression of bone markers, osteopontin (OPN), osteocalcin (OCN), biglycan (BGN), bone sialoprotein (BSP), and also a marker of vasculature, alpha-smooth muscle actin (α-SMA). This study provides evidence to support CMSCs and DMSCs as cellular candidates with potent bone forming capacity.

AB - Mesenchymal stem cells (MSCs) are one of the most attractive cell types for cell-based bone tissue repair applications. Fetal-derived MSCs and maternal-derived MSCs have been isolated from chorionic villi of human term placenta and the decidua basalis attached to the placenta following delivery, respectively. Chorionic-derived MSCs (CMSCs) and decidua-derived MSCs (DMSCs) generated in this study met the MSCs criteria set by International Society of Cellular Therapy. These criteria include: (i) adherence to plastic; (ii) >90% expression of CD73, CD105, CD90, CD146, CD44 and CD166 combined with <5% expression of CD45, CD19 and HLA-DR; and (iii) ability to differentiate into osteogenic, adipogenic, and chondrogenic lineages. In vivo subcutaneous implantation into SCID mice showed that both bromo-deoxyuridine (BrdU)-labelled CMSCs and DMSCs when implanted together with hydroxyapatite/tricalcium phosphate particles were capable of forming ectopic bone at 8-weeks post-transplantation. Histological assessment showed expression of bone markers, osteopontin (OPN), osteocalcin (OCN), biglycan (BGN), bone sialoprotein (BSP), and also a marker of vasculature, alpha-smooth muscle actin (α-SMA). This study provides evidence to support CMSCs and DMSCs as cellular candidates with potent bone forming capacity.

UR - http://www.scopus.com/inward/record.url?scp=84949057736&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0141246

DO - 10.1371/journal.pone.0141246

M3 - Article

VL - 10

JO - PLoS ONE

T2 - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 10

M1 - e0141246

ER -